Research progress on physiological activities and its mechanismof Beta-cryptoxanthin

Authors

SHENG Ran, Southwest University, Citrus Research Institute, Chongqing 400712, China
SUN Zhigao, Southwest University, Citrus Research Institute, Chongqing 400712, China
HUANG Qiaojuan, Guangdong Food And Drug Vocational-technical School, Guangzhou, Guangdong 510663, China
HAO Jingmei, Southwest University, Citrus Research Institute, Chongqing 400712, China
FANG Ming, Southwest University, Citrus Research Institute, Chongqing 400712, China
YU Fengsheng, Southwest University, Citrus Research Institute, Chongqing 400712, China

Abstract

The beta-cryptoxanthin is composed of multiple prenyl units, belonging to the oxidation of carotenoid. It widely exists in persimmon, citrus and other plants, and also can be produced by microbial fermentation..Based on beta-cryptoxanthin, the mechanism of its absorption and physiological activities was reviewed, in order to provide reference for improving research and clinic application of beta-cryptoxanthin.

Publication Date

12-28-2016

First Page

218

Last Page

223

DOI

10.13652/j.issn.1003-5788.2016.12.047

Recommended Citation

Ran, SHENG; Zhigao, SUN; Qiaojuan, HUANG; Jingmei, HAO; Ming, FANG; and Fengsheng, YU (2016) "Research progress on physiological activities and its mechanismof Beta-cryptoxanthin," Food and Machinery: Vol. 32: Iss. 12, Article 47.
DOI: 10.13652/j.issn.1003-5788.2016.12.047
Available at: https://www.ifoodmm.cn/journal/vol32/iss12/47

References

[1] 李涛, 张慧, 张志忠, 等. β-隐黄质的特性及其应用[J]. 中国食品添加剂, 2011(4): 156-158.
[2] 陶俊. 柑橘果实类胡萝卜素形成及调控的生理机制研究[D]. 杭州: 浙江大学, 2002: 26-36.
[3] GRANADO F, OLMEDILLA B, BLANCO I, et al. Major fruit and vegetable contributors to the main serum carotenoids in the Spanish diet[J]. European Journal of Clinical Nutrition, 1996, 50(4): 246-50.
[4] DURING A, DORAISWAMY S, HARRISON E H. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism[J]. Journal of Lipid Research, 2008, 49(8): 1 715-1 724.
[5] BOREL P, LIETZ G, GONCALVES A, et al. CD36 and SR-BI are involved in cellular uptakeof provitamin a carotenoids by Caco-2 and HEK Cells, and some of their genetic variants are associated with plasma concentrations of these micronutrients in humans[J]. The Journal of Nutrition, 2013, 143: 448-456.
[6] BURRI B J, LA FRANO M R, ZHU Cheng-hao. Absorption, metabolism, and functions of β-cryptoxanthin[J]. Nutrition Reviews, 2016, 74(2): 69-82.
[7] BURRI B J. Beta-cryptoxanthin as a source of vitamin A[J]. Journal of The Science of Food & Agriculture, 2014, 95(9): 1 786-1 794.
[8] NAMITHA K K, NEGI P S. Chemistry and Biotechnology of Carotenoids[J]. Critical Reviews in Food Science & Nutrition, 2010, 50(8): 728-760.
[9] BURRI B J, CHANG J S, NEIDLINGER T R. β-Cryptoxanthin- and α-carotene-rich foods have greater apparent bioavailability than β-carotene-rich foods in Western diets[J]. British Journal of Nutrition, 2011, 105(2): 212-219.
[10] VON L J. Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism[J]. Annual Review of Nutrition, 2010, 30(30): 35-56.
[11] AMENGUAL J, WIDJAJA-ADHI M A, RODRIGUEZ-SANTIAGO S, et al. Two carotenoid oxygenases contribute to mammalian provitamin A metabolism[J]. Journal of Biological Chemistry, 2013, 288(47): 34 081-34 096.
[12] DHUIQUE-MAYER C, BOREL P, REBOUL E, et al. β-Cryptoxanthin from Citrus juices: Assessment of bioaccessibility using an in vitro digestion/Caco-2 cell culture model[J]. British Journal of Nutrition, 2007, 97(5): 883-890.
[13] DAVIS C, JING H, HOWE J A. beta-Cryptoxanthin from supplements or carotenoid-enhanced maize maintains liver vitamin A in Mongolian gerbils ( Meriones unguiculatus) better than or equal to beta-carotene supplements[J]. British Journal of Nutrition, 2008, 100(4): 786-793.
[14] BURRI B J, CLIFFORD A J. Carotenoid and retinoid metabolism: Insights from isotope studies[J]. Archives of Biochemistry & Biophysics, 2004, 430(1): 110-119.
[15] HASKELL M J. The challenge to reach nutritional adequacy for vitamin A: beta-carotene bioavailability and conversion-evidence in humans[J]. American Journal of Clinical Nutrition, 2012, 96(5): 1 193S-1 203S.
[16] FERRUCCI L, PERRY J R B, MATTEINI A, et al. Common variation in the β-carotene 15,15′-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study[J]. American Journal of Human Genetics, 2009, 84(2): 123-133.
[17] LINDQVIST A, ANDERSSON S. Biochemical properties of purified recombinant human -carotene15,15 -monooxygenase[J]. The Journal of Biological Chemistry, 2002, 16(227)： 23 942-23 948.
[18] LIETZ G, OXLEY A, LEUNG W, et al. Single nucleotide polymorphisms upstream from the beta-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers[J]. Journal of Nutrition, 2012, 142(1): 161S-165S.
[19] HENDRICKSON S J, HAZRA A, CHEN Constance, et al. β-Carotene 15,15′-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent[J]. American Journal of Clinical Nutrition, 2012, 96(6): 1 379-1 389.
[20] DELA SEA C, SUN Jian, NARAYANASAMY S, et al. Substrate specificity of purified recombinant chicken β-carotene 9,10-oxygenase (BCO2)[J]. Journal of Biological Chemistry, DOI:10.1074/jbc.M116.723684.
[21] LIU Chun, BRONSON R T, RUSSELL R M, et al. β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets[J]. Cancer Prevention Research, 2011, 4(8): 1 255-1 266.
[22] ISKANDAR A R, LIU Chun, SMITH D E, et al. β-Cryptoxanthin restores nicotine-reduced lung sirt1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and Emphysema in A/J mice[J]. Cancer Prevention Research, 2013, 6(4): 309-320.
[23] LIAN Fu-zhi, HU Kang-quan, RUSSELL R M, et al. β-Cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor β expression[J]. International Journal of Cancer, 2006, 119(9): 2 084-2 089.
[24] MIYAZAWA K, MIYAMOTO S, SUZUKI R, et al. Dietary beta-cryptoxanthin inhibits n-butyl-n-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male icr mice[J]. Oncology Reports, 2007, 6(2): 297-304.
[25] NOGUCHI S, SUMIDA T, OGAWA H, et al. Effects of oxygenated carotenoid beta-cryptoxanthin on morphological differentiation and apoptosis in Neuro2a neuroblastoma cells[J]. Bioscience Biotechnology & Biochemistry, 2003, 67(11): 2 467-2 469.
[26] WU Can-jie, LI Han, RIAZ H, et al. The chemopreventive effect of β-cryptoxanthin from mandarin on human stomach cells (BGC-823)[J]. Food Chemistry, 2013, 136(3/4):1 122-1 129.
[27] CILLAA A, ATTANZIOB A, BARBERA R, et al. Anti-proliferative effect of main dietaryphytosterols and β-cryptox-anthin alone orcombined in human colon cancer Caco-2 cellsthrough cytosolic Ca+2- and oxidative stress-induced apoptosis[J]. Journal of Functional Foods, 2015, 12: 282-293.
[28] GHARIB A, FAEZIZADEH Z, GODARZEE M. Preparation and characterization of nanoliposomal beta-cryptoxanthin and its effect on proliferation and apoptosis in human leukemia cell line K562[J]. Tropical Journal of Pharmaceutical Research, 2015, 14(2): 187-194.
[29] LIU Xiao-ran, WANG Yue-ying, DAN Xin-gang, et al.Anti-inflammatory potential of beta-cryptoxanthin against LPS-induced inflammation in mouse Sertoli cells[J]. Reproductive Toxicology, 2016(60): 148-155.
[30] 黄巧娟, 孙志高, 龙勇, 等. D-柠檬烯抗癌机制的研究进展[J]. 食品科学, 2015, 36(7): 240-244.
[31] GRANADO-LORENCIO F, LAGARDA M J, GARCIA-LPEZ F J, et al. Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: A randomized crossover trial[J]. Nutrition Metabolism & Cardiovascular Diseases Nmcd, 2014, 24(10): 1 090-1 096.
[32] IKEDA N, SUGIYAMA T, SUZUKI T, et al. Effects of beta-cryptoxanthin on bone metabolism in a rat model of osteoporosis[J]. Journal of Animal & Veterinary Advances, 2012, 11(1): 30-35.
[33] YAMAGUCHI M, WEITZMANN M N. The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts[J]. Molecular Medicine Reports, 2009, 2(4): 641-644.
[34] YAMAGUCHI M, WEITZMANN M N. The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts[J]. International Journal of Molecular Medicine, 2009, 24(5): 671-675.
[35] UCHIYAMA S, SUMIDA T, YAMAGUCHI M. Anabolic effect of β-cryptoxanthin on bone components in the femoral tissues of aged rats in vivo and in vitro[J]. Journal of Health Science, 2004, 50(5): 491-496.
[36] UCHIYAMA S, YAMAGUCHI M. beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells[J]. Journal of Cellular Biochemistry, 2005, 95(6): 1 224-1 234.
[37] OZAKI K, OKAMOTO M, FUKASAWA K, et al. Daily intake of β-cryptoxanthin prevents bone loss by preferential disturbance of osteoclastic activation in ovariectomized mice[J]. Journal of Pharmacological Sciences, 2015, 129(1): 72-77.
[38] 孙谦, 胡中海, 孙志高, 等. 鱼腥草的生物活性及其机理研究进展[J]. 食品科学, 2014, 35(23): 354-358.
[39] JASWIR I, KOBAYASHI M, KOYAMA T, et al. Antioxidant behaviour of carotenoids highly accumulated in HepG2 cells[J]. Food Chemistry, 2012, 132(2): 865-872.
[40] LORENZO Y, AZQUETA A, LUNA L, et al. The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells[J]. Carcinogenesis, 2009, 30(2): 308-314.
[41] AZQUETA A, COLLINS A R. Carotenoids and DNA damage[J]. Mutation Research/Fundamental & Molecular Mechan-isms of Mutagenesis, 2012, 733(1/2): 4-13.
[42] CICCONE M M, CORTESE F, GESUALDO M, et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care[J]. Mediators of Inflammation, 2013, 2 013: 2 409-2 420.
[43] 河田照雄, 大山夏奈, 高橋信之. カロテノイド(5)β-クリプトキサンチン--糖·脂質代謝改善作用[J]. Functional Food, 2011, 4(4): 417-422.
[44] 蒋国玲. 温州蜜柑皮β-隐黄素的提取、纯化及稳定性研究[D]. 重庆: 西南大学, 2012: 8.
[45] DWYER J H, PAULLABRADOR M J, FAN J, et al. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study[J]. Arteriosclerosis Thrombosis & Vascular Biology, 2004, 24(24): 313-319.
[46] PATTISON D J, SYMMONS D P, LUNT M, et al. Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study[J]. American Journal of Clinical Nutrition, 2005, 82(2): 451-455.
[47] UNNO K. Prevention of senescence and stress by food composition[J]. Yakugaku Zasshi Journal of the Pharmaceutical Society of Japan, 2015, 135(1): 41-46.
[48] EICHINGER A, GORALCZYK R, WERTZ K, et al. Use of beta-cryptoxanthin: US, EP2005/005030 A1[P]. 2005-11-24.
[49] 向井, 克之. Novel application of β-cryptoxanthin for locomotive syndrome prevention[J]. 食品工業, 2013, 56(8): 46-50.
[50] HIKITA M, MOTOJIMA K, KAMATA S, et al. Protective efficacy of the ingestion of mandarin orange containing β-cryptoxanthin on lipopolysaccharide-induced acute nephritis[J]. Yakugaku Zasshi Journal of the Pharmaceutical Society of Japan, 2016, 136(7): 1 031-1 040.
[51] NISHI K, MURANAKA A, NISHIMOTO S, et al. Immunostimulatory effect of β-cryptoxanthin in vitro and in vivo[J]. Journal of Functional Foods, 2012, 4(3): 618-625.